GLP-1 receptor agonists hold key market opportunities due to their effectiveness in diabetes and obesity management, ...

Florida Atlantic University has received a $2.4 million grant from the National Institutes of Health to investigate how an immune-related receptor in neurons plays a fundamental role in brain function ...

A receptor involved in normal physiological processes may also drive breast cancer growth when overexpressed.

In studies published so far, GLP-1 receptor agonists appear to be beneficial for the treatment of glaucoma, according to a review published in Cureus.“GLP-1 RAs exert both protective and adverse ...

Opportunities in the GLP-1 receptor agonist market include the development of new diabetes and obesity treatments with high efficacy, a growing product pipeline, and increasing R&D investments. Rising ...

Researchers at Ohio University have discovered what may be a new way to fight lung cancer that is resistant to other ...

Clinical trials and equitable care pathways are needed to build on early evidence of benefit Substance use disorders (SUDs) are common and burdensome for patients, families, and health systems,12 yet ...

As key molecules on the surface of immune cells, Fc receptors are the core hub of antibody-mediated effector functions. They play an irreplaceable role in physiological processes such as ...

However, the measurement of sIL-2R is simple compared to the complex story behind this biomarker that has become so central to the study of immune-mediated disease. Why measure soluble interleukin-2 ...